QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma

NCT03132155 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Prematurely terminated due to lack of therapeutic effect

Conditions

Clear Cell Sarcoma

Interventions

DRUG: AMG 337

Sponsor

NantPharma, LLC